The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lescol XL 80 mg Prolonged-release tablets



Ethyx PharmaceuticalsPA23517/001/001

Main Information

Trade NameLescol XL 80 mg Prolonged-release tablets
Active SubstancesFluvastatin
Dosage FormProlonged-release tablet
Licence HolderEthyx Pharmaceuticals
Licence NumberPA23517/001/001

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA04 fluvastatin

Status

License statusAuthorised
Licence Issued23/01/2002
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back